USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NOVATARG, INC.
Address:
R DAVID THOMAS CENTER
BOX 90344
DURHAM, NC 27708-
Phone:
N/A
URL:
N/A
EIN:
127152179
DUNS:
962942863
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $731,339.00 2

Award List:

Advanced GST Proteomics for Early Stage Organ-Specific Toxicity Screening. Phase

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$316,261.00
Agency:
HHS
Principal Investigator:
Ken W. Batchelor – 919-354-1066
Abstract:
DESCRIPTION (provided by applicant): Type 2 diabetes (T2D) is a devastating disease that has undergone a striking increase in prevalence in the U.S. and worldwide. Although a number of different drugs exist to help manage this condition, unfortunately morethan 1/3 of affected individuals fail to… More

Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magneti

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$415,078.00
Agency:
HHS
Principal Investigator:
Ken W. Batchelor – 919-354-1066
Abstract:
DESCRIPTION (provided by applicant): There are approximately 12 million people suffering from autosomal dominant polycystic kidney disease (ADPKD) worldwide. ADPKD is a chronic condition with no effective drug therapies available; dialysis and transplantation are performed at costs of gt 2… More